MBX Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	727	616	-	-
Enterprise Value	503	339	-	-
Last Close Price	16.26	18.43	-	-
PB Ratio	2.49	2.39	-	-
P/TBV Ratio	3.32	2.39	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01
Quick Ratio	19.20	23.78	20.60	12.42
Current Ratio	19.50	24.19	21.26	12.89
Return on Equity (ROE)	-56.28%	-36.71%	-53.75%	-
Return on Assets (ROA)	-36.75%	-24.17%	-34.14%	-
Return on Capital (ROIC)	-39.40%	-25.23%	-36.20%	-
Earnings Yield	-10.60%	-10.05%	-	-
FCF Yield	-9.86%	-9.02%	-	-
Buyback Yield / Dilution	-2182.51%	-944.70%	-52.73%	-

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q